Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.

Saved in:
Bibliographic Details
Title: Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Authors: Kabbani, Dima1 (AUTHOR) dkabbani@ualberta.ca, Yotis, Demitra M2 (AUTHOR), Ferreira, Victor H3 (AUTHOR), Shalhoub, Sarah4 (AUTHOR), Belga, Sara5 (AUTHOR), Tyagi, Varalika1 (AUTHOR), Ierullo, Matthew3 (AUTHOR), Kulasingam, Vathany6 (AUTHOR), Hébert, Marie-Josée2,7 (AUTHOR), West, Lori2,8,9 (AUTHOR), Delisle, Jean-Sébastien2,10,11 (AUTHOR), Racine, Normand12 (AUTHOR), Serres, Sacha A De13 (AUTHOR), Cardinal, Héloïse10 (AUTHOR), Dieudé, Mélanie2,14,15,16 (AUTHOR), Humar, Atul3 (AUTHOR), Kumar, Deepali3 (AUTHOR) dkabbani@ualberta.ca
Source: Open Forum Infectious Diseases. May2023, Vol. 10 Issue 5, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofad200